-+ 0.00%
-+ 0.00%
-+ 0.00%

Minerva Neurosciences presents open-label safety trial data; roluperidone-olanzapine co-administration shows no safety concerns at SIRS 2026

Reuters·03/25/2026 20:05:44

Please log in to view news